Carisma Therapeutics (CARM)
NASDAQ:CARM
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Financial Statements

1,523 Followers

Carisma Therapeutics Financial Overview

Carisma Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.782; its P/E ratio is -0.56; Carisma Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 83.59M$ 90.79M$ 4.29M$ 3.80M$ 3.60M
Gross Profit$ 83.59M$ 90.79M$ 83.54M$ 3.80M$ 3.60M
EBIT$ -11.16M$ -18.74M$ -22.45M$ -21.43M$ -19.75M
EBITDA$ -7.70M$ -15.69M$ -21.73M$ -19.35M-
Net Income Common Stockholders$ -11.16M$ -18.98M$ -20.96M$ -21.43M$ -19.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.36M$ 56.52M$ 77.61M$ 94.14M$ 117.08M
Total Assets$ 59.34M$ 73.80M$ 89.55M$ 106.78M$ 133.01M
Total Debt$ 3.76M$ 7.49M$ 3.12M$ 2.75M$ 5.23M
Net Debt$ -36.60M$ -49.02M$ -74.48M$ -91.39M$ -111.85M
Total Liabilities$ 58.98M$ 62.90M$ 63.02M$ 60.49M$ 66.31M
Stockholders Equity$ 402.00K$ 10.88M$ 26.53M$ 46.30M$ 66.75M
Cash Flow-
Free Cash Flow$ -16.23M$ -22.44M$ -16.66M$ -21.19M-
Operating Cash Flow$ -16.12M$ -22.43M$ -16.10M$ -21.00M-
Investing Cash Flow$ -106.00K$ -17.00K$ 10.44M$ 29.81M-
Financing Cash Flow$ 73.00K$ 1.35M$ 101.00K$ -2.03M-
Currency in USD

Carisma Therapeutics Earnings and Revenue History

Carisma Therapeutics Debt to Assets

Carisma Therapeutics Cash Flow

Carisma Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis